Sanjay Goel
Director of Phase I / Investigational Therapeutics, Rutgers Cancer Institute/Jack & Sheryl Morris Cancer Center · Rutgers Health
Credentials: · · · · ·
History
- Present
Rutgers Cancer Institute/Jack & Sheryl Morris Cancer Center · Rutgers Health
- Present
- Present
Medical Oncology
Internal Medicine
Research
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
Cancer Discovery · 2020 · Co-first of 19 authors · Corresponding · 589 citations
Novel patterns of response under immunotherapy
Annals of Oncology · 2019 · 419 citations
Cancer Research · 2008 · 390 citations
26 papers
16 papers
11 papers
- SA
11 papers
- AA
9 papers · 5 as a fellow
9 papers
8 papers
- RP
8 papers
Grants
- 1997–2023
National Cancer Institute · P30
Project lead · $215.3K · Albert Einstein College of Medicine
- 2018–2021
Comparative Effectiveness of Biologic Agents in Ethnic Minorities with Colorectal Cancer
National Institute on Aging · R21
Contact PI · $397.2K · Montefiore Medical Center (Bronx, Ny)
Clinical trials
- 2020–2026
ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies
Principal investigator · Recruiting · Phase 1
Changchun Intellicrown Pharmaceutical Co. LTD
- 2008–2018
Exploratory Study Of The ERCC-1 Gene
Principal investigator · Completed
Albert Einstein College of Medicine